[Salt regimens modulation of neuroprotective effects of Magne B6 on the model of global cerebral stroke].
Gromova
O A
OA
Grishin
T R
TR
Sadin
A V
AV
Fedotova
L E
LE
Nikonov
A A
AA
Volkov
A Iu
AIu
D000818:Animals; D001205:Ascorbic Acid / Q000627:therapeutic use*; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000098:blood supply; D002545:Brain Ischemia / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D004195:Disease Models, Animal; D004338:Drug Combinations; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D017078:Laser-Doppler Flowmetry / Q000295:instrumentation; D008274:Magnesium / Q000627:therapeutic use*; D017616:Magnesium Compounds / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use*; D008275:Magnesium Deficiency / Q000150:complications; D008297:Male; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D051381:Rats; D012965:Sodium Chloride / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D025101:Vitamin B 6 / Q000627:therapeutic use*
D004338:Drug Combinations; C561664:Magne B6; D017616:Magnesium Compounds; D018696:Neuroprotective Agents; D012965:Sodium Chloride; D025101:Vitamin B 6; D008274:Magnesium; D001205:Ascorbic Acid